HX-1171

DB12162InvestigationalSmall molecule

Hx 1171 is under investigation in clinical trial NCT01548391 (A Phase I Clinical Study Study of the Safety, Tolerability, and Pharmacokinetics of HX-1171 in Healthy Male Subjects).

Mechanism: Pharmacologically active on Nuclear factor erythroid 2-related factor 2
Curator reviewed
Formula / weight: C₁₅H₂₄O₂ · 236.355 g/mol (avg)
Code names: HX-1171

Resolves to

Compound

UNII70BK60I8RPCAS148081-72-5ChEMBLCHEMBL3182532PubChem119193

Structure

InChIKeyATMNQRRJNBCQJO-UHFFFAOYSA-NSMILESCCCCCCOC1=CC(C)=C(O)C(C)=C1C

Targets

Q16236NFE2L2

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with HX-1171, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account